A single flu shot that could outperform vaccines?
CD388, a long-acting antiviral, showed 76% protection for a full flu season in early trials—one injection, no daily meds. Large-scale efficacy trials are planned for 2026.
https://www.science.org/content/article/single-shot-flu-drug-could-outperform-vaccines-and-protect-entire-season #press